Overview

A mid-cap biopharma company was launching a gene therapy product for sickle cell disease. RxC was asked to develop an early commercialization strategy.

Approach

RxC worked closely with the client team to:

• Generate insight through market mapping, HCP profiling, and segmentation

• Create a strategy for brand development through analysis of the situation from the patient journey to PEST to SWOT, as well as understanding differentiation and position

• Form a brand identification for brand development through core visual aid development

Results

The client has leveraged RxC plan to further advance the commercialization efforts.